1. Home
  2. PROK vs LHSW Comparison

PROK vs LHSW Comparison

Compare PROK & LHSW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PROK
  • LHSW
  • Stock Information
  • Founded
  • PROK 2015
  • LHSW 2007
  • Country
  • PROK United States
  • LHSW China
  • Employees
  • PROK N/A
  • LHSW N/A
  • Industry
  • PROK Biotechnology: Biological Products (No Diagnostic Substances)
  • LHSW
  • Sector
  • PROK Health Care
  • LHSW
  • Exchange
  • PROK Nasdaq
  • LHSW NYSE
  • Market Cap
  • PROK 94.9M
  • LHSW 81.6M
  • IPO Year
  • PROK N/A
  • LHSW 2025
  • Fundamental
  • Price
  • PROK $0.98
  • LHSW $2.30
  • Analyst Decision
  • PROK Buy
  • LHSW
  • Analyst Count
  • PROK 4
  • LHSW 0
  • Target Price
  • PROK $5.00
  • LHSW N/A
  • AVG Volume (30 Days)
  • PROK 522.0K
  • LHSW 807.8K
  • Earning Date
  • PROK 05-12-2025
  • LHSW 01-01-0001
  • Dividend Yield
  • PROK N/A
  • LHSW N/A
  • EPS Growth
  • PROK N/A
  • LHSW N/A
  • EPS
  • PROK N/A
  • LHSW 0.05
  • Revenue
  • PROK $306,000.00
  • LHSW $36,718,017.00
  • Revenue This Year
  • PROK $54.34
  • LHSW N/A
  • Revenue Next Year
  • PROK N/A
  • LHSW N/A
  • P/E Ratio
  • PROK N/A
  • LHSW $46.08
  • Revenue Growth
  • PROK N/A
  • LHSW 24.85
  • 52 Week Low
  • PROK $0.46
  • LHSW $0.99
  • 52 Week High
  • PROK $3.43
  • LHSW $8.18
  • Technical
  • Relative Strength Index (RSI)
  • PROK 65.88
  • LHSW N/A
  • Support Level
  • PROK $0.75
  • LHSW N/A
  • Resistance Level
  • PROK $0.82
  • LHSW N/A
  • Average True Range (ATR)
  • PROK 0.07
  • LHSW 0.00
  • MACD
  • PROK 0.03
  • LHSW 0.00
  • Stochastic Oscillator
  • PROK 88.17
  • LHSW 0.00

About PROK ProKidney Corp.

ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.

About LHSW LIANHE SOWELL INTERNATIONAL GROUP L

Lianhe Sowell International Group Ltd is a holding company and operates its business through its subsidiary. It is a provider of machine vision products and solutions in China that invent and integrate technologies and solutions that address some of the most critical manufacturing and distribution challenges, such as precision and accuracy required in manufacturing of electronic products. The company categorize machine vision products in four categories based on their application settings: Industrial Machine Vision, Artificial Intelligence (Face Recognition and AI Behavior Analysis), Intelligent Weak Current (Building Intelligence and Intelligent Transportation) and Electronic Customs Clearance.

Share on Social Networks: